Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI

Mucopolysaccharidosis type VI

Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) A Study in MPS VI to Assess Safety and Efficacy of Odiparcil Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI Stem Cell Transplantation for Hurler Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease Network Clinical Trial of Growth Hormone in MPS I, II, and VI Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI Gene Therapy in Patients With Mucopolysaccharidosis Disease Observational Study of Patients With Mucopolysaccharidosis (MPS) VI Who Previously Participated in ASB-00-02 Study of rhASB in Patients With Mucopolysaccharidosis VI A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome